Ticker Details
ZOETIS INC. Zoetis Inc is a developer and manufacturer of drugs providing medicines for animal health, and vaccines for livestock and companion animals. Its products are anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
IPO Date:	February 1, 2013
Sector:	Healthcare
Industry:	Drug Manufacturers
Market Cap:	$31.48B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.24 | 1.09%
Avg Daily Range (30 D):	$1.20 | 1.53%
Avg Daily Range (90 D):	$1.66 | 1.70%

Institutional Daily Volume
Avg Daily Volume:	2.55M
Avg Daily Volume (30 D):	5.26M
Avg Daily Volume (90 D):	4.73M

Trade Size
Avg Trade Size (Sh.):	90
Avg Trade Size (Sh.) (30 D):	73
Avg Trade Size (Sh.) (90 D):	69

Institutional Trades
Total Institutional Trades:	29,076
Avg Institutional Trade:	$7.99M
Avg Institutional Trade (30 D):	$9.94M
Avg Institutional Trade (90 D):	$8.8M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	8

Market Closing Trades
Avg Closing Trade:	$35.9M
Avg Closing Trade (30 D):	$101.24M
Avg Closing Trade (90 D):	$90.49M
Avg Closing Volume:	316.03K

News

Jul 6, 2026 @ 5:48 PM Deadline Alert: Zoetis Inc. (ZTS) Shareholders Who... Source: Glancy Prongay Wolke & Rotter Llp

Jul 6, 2026 @ 4:00 PM Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc... Source: Bronstein, Gewirtz & Grossman Llc

Jul 4, 2026 @ 10:15 PM ZTS DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNS... Source: Rosen Law Firm

Jul 4, 2026 @ 10:15 PM ZTS 截止日期提醒：Ã... Source: Rosen Law Firm

Jul 2, 2026 @ 4:00 PM Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc... Source: Bronstein, Gewirtz & Grossman Llc

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$6.04	$1.42	$1.38
Diluted EPS	$6.03	$1.42	$1.37
Revenue	$9.51B	$2.26B	$2.39B
Gross Profit	$6.82B	$1.62B	$1.68B
Net Income / Loss	$2.64B	$601M	$603M
Operating Income / Loss	$3.31B	$758M	$761M
Cost of Revenue	$2.69B	$641M	$712M
Net Cash Flow	$148M	$-509M	$228M
PE Ratio